Characteristics of pediatric ulcerative colitis in Saudi Arabia: a multicenter national study

Khalid AlSaleem1, Mohammad Issa El Mouzan, Omar I Saadah

  • 1Dr. Khalid AlSaleem, MBC 58 Department of Pediatrics,, King Faisal Specialist Hospital and Research Centre,, PO Box 3354, Riyadh 11211,, Saudi Arabia, T: 966505445487, ksaleem@kfshrc.edu.sa.

Insights

Pediatric ulcerative colitis (UC) is increasingly diagnosed in Saudi Arabia, with common symptoms including blood in stool and diarrhea. This study highlights similarities in UC presentation to Western countries, noting a high prevalence of consanguinity.

Area of Science:

  • Pediatric gastroenterology
  • Inflammatory Bowel Disease (IBD) research
  • Epidemiology of gastrointestinal disorders

Background:

  • Limited data on pediatric ulcerative colitis (UC) exists from developing nations, contrasting with extensive reports from industrialized countries.
  • Previous studies on pediatric UC in Saudi Arabia were primarily small, single-center case series.
  • This multicenter study addresses the need for comprehensive data on pediatric UC in Saudi Arabia.

Purpose of the Study:

  • To investigate the clinical, laboratory, and endoscopic characteristics of pediatric ulcerative colitis (UC) in Saudi Arabia.
  • To establish a large, multicenter dataset for pediatric UC in a developing country.
  • To compare findings with international data from North America and Europe.

Main Methods:

  • Retrospective analysis of pediatric patients diagnosed with UC (under 18 years) between 2003 and 2012.
  • Data collected from 15 medical centers across Saudi Arabia using a unified database form.
  • Inclusion criteria focused on confirmed UC diagnoses in children.

Main Results:

  • 188 children diagnosed with UC; 51.6% males, mean age at diagnosis 9.1 years.
  • High prevalence of consanguinity (32.6%) and family history of IBD (9%).
  • Common symptoms: blood in stool (90%), diarrhea (86%), abdominal pain (62%); elevated ESR (82%), anemia (75%), thrombocytosis (72%).

Conclusions:

  • Pediatric UC is increasingly recognized in Saudi Arabia, with clinical presentations similar to Western countries.
  • Age-related variations in IBD distribution were observed.
  • High rates of consanguinity and family history in young UC patients warrant further investigation.
Abstract

Related Concept Videos

Inflammatory Bowel Disease I: Ulcerative Colitis01:27

Inflammatory Bowel Disease I: Ulcerative Colitis

Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
1.5K
Drugs for Treatment of Ulcerative Colitis in IBD01:29

Drugs for Treatment of Ulcerative Colitis in IBD

Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
654
Chronic Bowel Disorders: Introduction01:17

Chronic Bowel Disorders: Introduction

Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
944
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies01:28

Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies

Peptic ulcer disease (PUD) presents with diverse symptoms depending on the location and severity of the ulcer. Clinical manifestations of peptic ulcer include dull pain and a burning sensation in the mid-epigastric region.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
820
Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
1.5K
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
1.1K